25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS
Buy, Hold or Sell?

Let's analyze Meditera together

I guess you are interested in Meditera Tibbi Malzeme Sanayi ve Ticaret AS. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Meditera Tibbi Malzeme Sanayi ve Ticaret AS. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Meditera Tibbi Malzeme Sanayi ve Ticaret AS

I send you an email if I find something interesting about Meditera Tibbi Malzeme Sanayi ve Ticaret AS.

1. Quick Overview

1.1. Quick analysis of Meditera (30 sec.)










1.2. What can you expect buying and holding a share of Meditera? (30 sec.)

How much money do you get?

How much money do you get?
₺0.15
When do you have the money?
1 year
How often do you get paid?
66.7%

What is your share worth?

Current worth
₺12.43
Expected worth in 1 year
₺32.36
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
₺24.96
Return On Investment
58.8%

For what price can you sell your share?

Current Price per Share
₺42.48
Expected price per share
₺39.88 - ₺49.96
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Meditera (5 min.)




Live pricePrice per Share (EOD)
₺42.48
Intrinsic Value Per Share
₺-5.31 - ₺-1.83
Total Value Per Share
₺7.13 - ₺10.61

2.2. Growth of Meditera (5 min.)




Is Meditera growing?

Current yearPrevious yearGrowGrow %
How rich?$43.5m$26m$17.4m40.1%

How much money is Meditera making?

Current yearPrevious yearGrowGrow %
Making money$760.4k$8.7m-$7.9m-1,048.4%
Net Profit Margin1.8%36.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Meditera (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Meditera?

Welcome investor! Meditera's management wants to use your money to grow the business. In return you get a share of Meditera.

First you should know what it really means to hold a share of Meditera. And how you can make/lose money.

Speculation

The Price per Share of Meditera is ₺42.48. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Meditera.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Meditera, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₺12.43. Based on the TTM, the Book Value Change Per Share is ₺4.98 per quarter. Based on the YOY, the Book Value Change Per Share is ₺2.67 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₺1.26 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Meditera.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.010.0%0.010.0%0.070.2%0.030.1%0.020.1%
Usd Book Value Change Per Share0.150.3%0.150.3%0.080.2%0.070.2%0.060.1%
Usd Dividend Per Share0.040.1%0.040.1%0.030.1%0.030.1%0.020.1%
Usd Total Gains Per Share0.180.4%0.180.4%0.110.3%0.100.2%0.080.2%
Usd Price Per Share0.82-0.82-1.18-0.70-0.59-
Price to Earnings Ratio128.08-128.08-16.03-36.15-30.12-
Price-to-Total Gains Ratio4.46-4.46-10.40-9.11-9.11-
Price to Book Ratio2.24-2.24-5.37-3.68-3.07-
Price-to-Total Gains Ratio4.46-4.46-10.40-9.11-9.11-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.248912
Number of shares800
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.03
Usd Book Value Change Per Share0.150.07
Usd Total Gains Per Share0.180.10
Gains per Quarter (800 shares)146.7976.75
Gains per Year (800 shares)587.15307.01
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
111946957790217297
22379371164180434604
335614061751270651911
4474187423383618681218
55932343292545110841525
67122811351254113011832
78303280409963115182139
89493748468672117352446
910674217527381119522753
1011864686586090121693060

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%4.00.01.080.0%4.00.02.066.7%4.00.02.066.7%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Meditera Tibbi Malzeme Sanayi ve Ticaret AS compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--4.9804.9800%2.670+87%2.305+116%2.072+140%
Book Value Per Share--12.43512.4350%7.454+67%5.512+126%4.745+162%
Current Ratio--3.7953.7950%4.969-24%3.731+2%3.531+7%
Debt To Asset Ratio--0.2180.2180%0.193+13%0.282-23%0.313-30%
Debt To Equity Ratio--0.2800.2800%0.240+17%0.551-49%0.749-63%
Dividend Per Share--1.2611.2610%1.176+7%0.958+32%0.798+58%
Eps--0.2170.2170%2.496-91%0.948-77%0.807-73%
Free Cash Flow Per Share---0.036-0.0360%-0.394+987%0.047-177%0.142-126%
Free Cash Flow To Equity Per Share---0.036-0.0360%-1.446+3890%0.128-128%0.209-117%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.830--------
Intrinsic Value_10Y_min---5.309--------
Intrinsic Value_1Y_max---0.003--------
Intrinsic Value_1Y_min---0.186--------
Intrinsic Value_3Y_max---0.146--------
Intrinsic Value_3Y_min---0.861--------
Intrinsic Value_5Y_max---0.455--------
Intrinsic Value_5Y_min---1.864--------
Market Cap5055120000.000+34%3312960000.0003312960000.0000%4762380000.000-30%2843145620.000+17%2369288016.667+40%
Net Profit Margin--0.0180.0180%0.369-95%0.211-92%0.186-90%
Operating Margin----0%0.283-100%0.160-100%0.134-100%
Operating Ratio--1.3731.3730%1.251+10%1.332+3%1.336+3%
Pb Ratio3.416+34%2.2392.2390%5.369-58%3.678-39%3.065-27%
Pe Ratio195.434+34%128.081128.0810%16.033+699%36.146+254%30.121+325%
Price Per Share42.480+34%27.84027.8400%40.020-30%23.892+17%19.910+40%
Price To Free Cash Flow Ratio-1172.360-53%-768.326-768.3260%-101.604-87%-129.191-83%-107.659-86%
Price To Total Gains Ratio6.807+34%4.4614.4610%10.405-57%9.114-51%9.114-51%
Quick Ratio--1.9841.9840%3.613-45%2.088-5%1.966+1%
Return On Assets--0.0140.0140%0.270-95%0.150-91%0.136-90%
Return On Equity--0.0180.0180%0.335-95%0.223-92%0.224-92%
Total Gains Per Share--6.2416.2410%3.846+62%3.263+91%2.871+117%
Usd Book Value--43504571.62043504571.6200%26080093.729+67%19285460.788+126%16600979.422+162%
Usd Book Value Change Per Share--0.1460.1460%0.078+87%0.068+116%0.061+140%
Usd Book Value Per Share--0.3660.3660%0.219+67%0.162+126%0.140+162%
Usd Dividend Per Share--0.0370.0370%0.035+7%0.028+32%0.023+58%
Usd Eps--0.0060.0060%0.073-91%0.028-77%0.024-73%
Usd Free Cash Flow---126770.419-126770.4190%-1378036.094+987%163966.405-177%495602.400-126%
Usd Free Cash Flow Per Share---0.001-0.0010%-0.012+987%0.001-177%0.004-126%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%-0.043+3890%0.004-128%0.006-117%
Usd Market Cap148620528.000+34%97401024.00097401024.0000%140013972.000-30%83588481.228+17%69657067.690+40%
Usd Price Per Share1.249+34%0.8180.8180%1.177-30%0.702+17%0.585+40%
Usd Profit--760465.427760465.4270%8733132.643-91%3314977.525-77%2823674.843-73%
Usd Revenue--42696666.52942696666.5290%23697555.126+80%18966786.644+125%16782854.133+154%
Usd Total Gains Per Share--0.1830.1830%0.113+62%0.096+91%0.084+117%
 EOD+5 -3MRQTTM+0 -0YOY+18 -175Y+18 -1710Y+19 -16

3.3 Fundamental Score

Let's check the fundamental score of Meditera Tibbi Malzeme Sanayi ve Ticaret AS based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15195.434
Price to Book Ratio (EOD)Between0-13.416
Net Profit Margin (MRQ)Greater than00.018
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.984
Current Ratio (MRQ)Greater than13.795
Debt to Asset Ratio (MRQ)Less than10.218
Debt to Equity Ratio (MRQ)Less than10.280
Return on Equity (MRQ)Greater than0.150.018
Return on Assets (MRQ)Greater than0.050.014
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Meditera Tibbi Malzeme Sanayi ve Ticaret AS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.649
Ma 20Greater thanMa 5042.285
Ma 50Greater thanMa 10038.691
Ma 100Greater thanMa 20035.218
OpenGreater thanClose41.520
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Meditera Tibbi Malzeme Sanayi ve Ticaret AS

Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi manufactures and sells medical devices in Turkey. The company offers breathing sytems products, including breathing circuits, breathing filters, catheter mounts, gas sampling lines, accessories, masks, and connectors. It also provides hospital products, such as barrier cream, surgical hand brushes for skin disinfection, hand and skin antiseptics, and skin and mucosa antiseptics. In addition, the company engages in the manufacturing and sale of anesthesia and intensive care circuits; installation, operation, and design of oncology drug preparation and delivery systems; production, sales, and technical service of infusion pumps and sets; and manufacturing of biocidal products. It also exports its products to 80 countries under its Altech brand name. Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi was founded in 1983 and is headquartered in Izmir, Turkey.

Fundamental data was last updated by Penke on 2024-08-29 14:53:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Meditera earns for each ₤1 of revenue.

  • Above 10% is considered healthy but always compare Meditera to the Medical Devices industry mean.
  • A Net Profit Margin of 1.8% means that ₤0.02 for each ₤1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Meditera Tibbi Malzeme Sanayi ve Ticaret AS:

  • The MRQ is 1.8%. The company is making a profit. +1
  • The TTM is 1.8%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.8%TTM1.8%0.0%
TTM1.8%YOY36.9%-35.1%
TTM1.8%5Y21.1%-19.3%
5Y21.1%10Y18.6%+2.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%-11.6%+13.4%
TTM1.8%-16.1%+17.9%
YOY36.9%-16.0%+52.9%
5Y21.1%-18.9%+40.0%
10Y18.6%-24.6%+43.2%
4.3.1.2. Return on Assets

Shows how efficient Meditera is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Meditera to the Medical Devices industry mean.
  • 1.4% Return on Assets means that Meditera generated ₤0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Meditera Tibbi Malzeme Sanayi ve Ticaret AS:

  • The MRQ is 1.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.4%TTM1.4%0.0%
TTM1.4%YOY27.0%-25.7%
TTM1.4%5Y15.0%-13.7%
5Y15.0%10Y13.6%+1.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4%-3.2%+4.6%
TTM1.4%-3.9%+5.3%
YOY27.0%-3.7%+30.7%
5Y15.0%-3.4%+18.4%
10Y13.6%-4.0%+17.6%
4.3.1.3. Return on Equity

Shows how efficient Meditera is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Meditera to the Medical Devices industry mean.
  • 1.8% Return on Equity means Meditera generated ₤0.02 for each ₤1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Meditera Tibbi Malzeme Sanayi ve Ticaret AS:

  • The MRQ is 1.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.8%TTM1.8%0.0%
TTM1.8%YOY33.5%-31.8%
TTM1.8%5Y22.3%-20.6%
5Y22.3%10Y22.4%-0.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%-3.9%+5.7%
TTM1.8%-4.6%+6.4%
YOY33.5%-4.2%+37.7%
5Y22.3%-5.0%+27.3%
10Y22.4%-5.6%+28.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Meditera Tibbi Malzeme Sanayi ve Ticaret AS.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Meditera is operating .

  • Measures how much profit Meditera makes for each ₤1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Meditera to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated ₤0.00  for each ₤1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Meditera Tibbi Malzeme Sanayi ve Ticaret AS:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY28.3%-28.3%
TTM-5Y16.0%-16.0%
5Y16.0%10Y13.4%+2.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--7.8%+7.8%
TTM--15.9%+15.9%
YOY28.3%-10.8%+39.1%
5Y16.0%-17.7%+33.7%
10Y13.4%-22.4%+35.8%
4.3.2.2. Operating Ratio

Measures how efficient Meditera is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.37 means that the operating costs are ₤1.37 for each ₤1 in net sales.

Let's take a look of the Operating Ratio trends of Meditera Tibbi Malzeme Sanayi ve Ticaret AS:

  • The MRQ is 1.373. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.373. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.373TTM1.3730.000
TTM1.373YOY1.251+0.122
TTM1.3735Y1.332+0.041
5Y1.33210Y1.336-0.004
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3731.475-0.102
TTM1.3731.402-0.029
YOY1.2511.425-0.174
5Y1.3321.418-0.086
10Y1.3361.402-0.066
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Meditera Tibbi Malzeme Sanayi ve Ticaret AS.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Meditera is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.79 means the company has ₤3.79 in assets for each ₤1 in short-term debts.

Let's take a look of the Current Ratio trends of Meditera Tibbi Malzeme Sanayi ve Ticaret AS:

  • The MRQ is 3.795. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.795. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.795TTM3.7950.000
TTM3.795YOY4.969-1.175
TTM3.7955Y3.731+0.063
5Y3.73110Y3.531+0.201
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7952.547+1.248
TTM3.7952.618+1.177
YOY4.9693.076+1.893
5Y3.7313.521+0.210
10Y3.5313.594-0.063
4.4.3.2. Quick Ratio

Measures if Meditera is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Meditera to the Medical Devices industry mean.
  • A Quick Ratio of 1.98 means the company can pay off ₤1.98 for each ₤1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Meditera Tibbi Malzeme Sanayi ve Ticaret AS:

  • The MRQ is 1.984. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.984. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.984TTM1.9840.000
TTM1.984YOY3.613-1.629
TTM1.9845Y2.088-0.104
5Y2.08810Y1.966+0.123
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9841.099+0.885
TTM1.9841.420+0.564
YOY3.6131.960+1.653
5Y2.0882.518-0.430
10Y1.9662.604-0.638
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Meditera Tibbi Malzeme Sanayi ve Ticaret AS.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Meditera assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Meditera to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.22 means that Meditera assets are financed with 21.8% credit (debt) and the remaining percentage (100% - 21.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Meditera Tibbi Malzeme Sanayi ve Ticaret AS:

  • The MRQ is 0.218. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.218. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.218TTM0.2180.000
TTM0.218YOY0.193+0.025
TTM0.2185Y0.282-0.064
5Y0.28210Y0.313-0.031
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2180.412-0.194
TTM0.2180.412-0.194
YOY0.1930.355-0.162
5Y0.2820.440-0.158
10Y0.3130.462-0.149
4.5.4.2. Debt to Equity Ratio

Measures if Meditera is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Meditera to the Medical Devices industry mean.
  • A Debt to Equity ratio of 28.0% means that company has ₤0.28 debt for each ₤1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Meditera Tibbi Malzeme Sanayi ve Ticaret AS:

  • The MRQ is 0.280. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.280. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.280TTM0.2800.000
TTM0.280YOY0.240+0.040
TTM0.2805Y0.551-0.270
5Y0.55110Y0.749-0.199
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2800.587-0.307
TTM0.2800.595-0.315
YOY0.2400.523-0.283
5Y0.5510.618-0.067
10Y0.7490.688+0.061
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₤1 in earnings Meditera generates.

  • Above 15 is considered overpriced but always compare Meditera to the Medical Devices industry mean.
  • A PE ratio of 128.08 means the investor is paying ₤128.08 for every ₤1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Meditera Tibbi Malzeme Sanayi ve Ticaret AS:

  • The EOD is 195.434. Based on the earnings, the company is expensive. -2
  • The MRQ is 128.081. Based on the earnings, the company is expensive. -2
  • The TTM is 128.081. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD195.434MRQ128.081+67.353
MRQ128.081TTM128.0810.000
TTM128.081YOY16.033+112.048
TTM128.0815Y36.146+91.935
5Y36.14610Y30.121+6.024
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD195.434-1.009+196.443
MRQ128.081-1.423+129.504
TTM128.081-2.130+130.211
YOY16.033-2.109+18.142
5Y36.146-2.241+38.387
10Y30.121-2.014+32.135
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Meditera Tibbi Malzeme Sanayi ve Ticaret AS:

  • The EOD is -1,172.360. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -768.326. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -768.326. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1,172.360MRQ-768.326-404.034
MRQ-768.326TTM-768.3260.000
TTM-768.326YOY-101.604-666.722
TTM-768.3265Y-129.191-639.135
5Y-129.19110Y-107.659-21.532
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1,172.360-1.710-1,170.650
MRQ-768.326-2.470-765.856
TTM-768.326-1.826-766.500
YOY-101.604-5.914-95.690
5Y-129.191-4.813-124.378
10Y-107.659-5.704-101.955
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Meditera is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 2.24 means the investor is paying ₤2.24 for each ₤1 in book value.

Let's take a look of the Price to Book Ratio trends of Meditera Tibbi Malzeme Sanayi ve Ticaret AS:

  • The EOD is 3.416. Based on the equity, the company is fair priced.
  • The MRQ is 2.239. Based on the equity, the company is underpriced. +1
  • The TTM is 2.239. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.416MRQ2.239+1.177
MRQ2.239TTM2.2390.000
TTM2.239YOY5.369-3.130
TTM2.2395Y3.678-1.440
5Y3.67810Y3.065+0.613
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD3.4162.074+1.342
MRQ2.2392.116+0.123
TTM2.2392.326-0.087
YOY5.3692.973+2.396
5Y3.6784.148-0.470
10Y3.0654.774-1.709
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in TRY. All numbers in thousands.

Summary
Total Assets1,892,926
Total Liabilities413,179
Total Stockholder Equity1,474,124
 As reported
Total Liabilities 413,179
Total Stockholder Equity+ 1,474,124
Total Assets = 1,892,926

Assets

Total Assets1,892,926
Total Current Assets1,080,396
Long-term Assets812,530
Total Current Assets
Cash And Cash Equivalents 150,000
Short-term Investments 275,123
Net Receivables 289,829
Inventory 275,410
Other Current Assets 47
Total Current Assets  (as reported)1,080,396
Total Current Assets  (calculated)990,408
+/- 89,988
Long-term Assets
Property Plant Equipment 757,773
Intangible Assets 931
Long-term Assets  (as reported)812,530
Long-term Assets  (calculated)758,703
+/- 53,827

Liabilities & Shareholders' Equity

Total Current Liabilities284,722
Long-term Liabilities128,457
Total Stockholder Equity1,474,124
Total Current Liabilities
Short Long Term Debt 40,918
Accounts payable 202,760
Total Current Liabilities  (as reported)284,722
Total Current Liabilities  (calculated)243,678
+/- 41,044
Long-term Liabilities
Long term Debt 45,273
Capital Lease Obligations Min Short Term Debt247
Long-term Liabilities  (as reported)128,457
Long-term Liabilities  (calculated)45,520
+/- 82,937
Total Stockholder Equity
Retained Earnings 350,677
Total Stockholder Equity (as reported)1,474,124
Total Stockholder Equity (calculated)350,677
+/- 1,123,447
Other
Capital Stock119,000
Common Stock Shares Outstanding 119,000
Net Invested Capital 1,560,315
Net Working Capital 795,674
Property Plant and Equipment Gross 1,694,762



6.2. Balance Sheets Structured

Currency in TRY. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
> Total Assets 
203,470
220,213
341,686
719,211
1,099,488
1,892,926
1,892,9261,099,488719,211341,686220,213203,470
   > Total Current Assets 
153,282
166,005
241,132
618,338
720,125
1,080,396
1,080,396720,125618,338241,132166,005153,282
       Cash And Cash Equivalents 
14,063
5,994
55,694
261,278
97,758
150,000
150,00097,758261,27855,6945,99414,063
       Short-term Investments 
0
0
0
133,290
266,080
275,123
275,123266,080133,290000
       Net Receivables 
82,057
105,463
116,037
130,448
257,508
289,829
289,829257,508130,448116,037105,46382,057
       Inventory 
42,058
37,680
49,526
66,612
157,132
275,410
275,410157,13266,61249,52637,68042,058
       Other Current Assets 
9,803
11,254
18,752
16,751
27,305
47
4727,30516,75118,75211,2549,803
   > Long-term Assets 
50,188
54,208
100,555
100,873
379,363
812,530
812,530379,363100,873100,55554,20850,188
       Property Plant Equipment 
0
48,070
89,488
85,240
301,667
757,773
757,773301,66785,24089,48848,0700
       Intangible Assets 
586
393
642
597
813
931
931813597642393586
       Other Assets 
0
0
9,924
15,036
16,234
0
016,23415,0369,92400
> Total Liabilities 
95,356
93,724
124,532
149,839
212,410
413,179
413,179212,410149,839124,53293,72495,356
   > Total Current Liabilities 
60,648
73,034
87,624
127,036
144,918
284,722
284,722144,918127,03687,62473,03460,648
       Short Long Term Debt 
22,769
24,448
17,908
23,374
13,976
40,918
40,91813,97623,37417,90824,44822,769
       Accounts payable 
32,049
33,560
53,797
70,075
107,158
202,760
202,760107,15870,07553,79733,56032,049
       Other Current Liabilities 
0
0
9,213
26,938
11,264
0
011,26426,9389,21300
   > Long-term Liabilities 
34,708
20,691
36,909
22,802
67,492
128,457
128,45767,49222,80236,90920,69134,708
       Long term Debt 
30,488
14,267
24,577
6,427
36,898
45,273
45,27336,8986,42724,57714,26730,488
       Capital Lease Obligations Min Short Term Debt
0
0
6,879
1,328
492
247
2474921,3286,87900
       Other Liabilities 
0
0
11,112
15,332
30,378
0
030,37815,33211,11200
       Long-term Liabilities Other 
0
0
0
0
0
0
000000
> Total Stockholder Equity
54,699
67,139
217,154
569,372
885,607
1,474,124
1,474,124885,607569,372217,15467,13954,699
   Common Stock
0
0
27,000
34,000
119,000
0
0119,00034,00027,00000
   Retained Earnings 
24,493
36,688
160,201
327,902
484,947
350,677
350,677484,947327,902160,20136,68824,493
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
0
0
29,953
30,255
189,753
0
0189,75330,25529,95300



6.3. Balance Sheets

Currency in TRY. All numbers in thousands.




6.4. Cash Flows

Currency in TRY. All numbers in thousands.




6.5. Income Statements

Currency in TRY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in TRY. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,452,268
Cost of Revenue-808,545
Gross Profit643,723643,723
 
Operating Income (+$)
Gross Profit643,723
Operating Expense-1,185,841
Operating Income266,427-542,118
 
Operating Expense (+$)
Research Development13,900
Selling General Administrative114,335
Selling And Marketing Expenses0
Operating Expense1,185,841128,235
 
Net Interest Income (+$)
Interest Income55,208
Interest Expense-52,707
Other Finance Cost-1,038
Net Interest Income1,463
 
Pretax Income (+$)
Operating Income266,427
Net Interest Income1,463
Other Non-Operating Income Expenses0
Income Before Tax (EBT)55,587266,427
EBIT - interestExpense = -52,707
25,866
78,574
Interest Expense52,707
Earnings Before Interest and Taxes (EBIT)0108,294
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax55,587
Tax Provision-29,678
Net Income From Continuing Ops25,90925,909
Net Income25,866
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-1,463
 

Technical Analysis of Meditera
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Meditera. The general trend of Meditera is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Meditera's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Meditera Tibbi Malzeme Sanayi ve Ticaret AS.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 47.66 < 49.96.

The bearish price targets are: 40.46 > 39.92 > 39.88.

Tweet this
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Meditera Tibbi Malzeme Sanayi ve Ticaret AS. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Meditera Tibbi Malzeme Sanayi ve Ticaret AS. The current macd is 1.66639114.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Meditera price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Meditera. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Meditera price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Moving Average Convergence/Divergence (MACD) ChartMeditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Meditera Tibbi Malzeme Sanayi ve Ticaret AS. The current adx is 19.42.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Meditera shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Meditera Tibbi Malzeme Sanayi ve Ticaret AS. The current sar is 49.01.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Meditera Tibbi Malzeme Sanayi ve Ticaret AS. The current rsi is 54.65. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Relative Strength Index (RSI) ChartMeditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Meditera Tibbi Malzeme Sanayi ve Ticaret AS. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Meditera price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Stochastic Oscillator ChartMeditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Meditera Tibbi Malzeme Sanayi ve Ticaret AS. The current cci is -4.16445153.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Commodity Channel Index (CCI) ChartMeditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Meditera Tibbi Malzeme Sanayi ve Ticaret AS. The current cmo is -1.11042637.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Chande Momentum Oscillator (CMO) ChartMeditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Meditera Tibbi Malzeme Sanayi ve Ticaret AS. The current willr is -70.03745318.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Meditera is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Williams %R ChartMeditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Meditera Tibbi Malzeme Sanayi ve Ticaret AS.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Meditera Tibbi Malzeme Sanayi ve Ticaret AS. The current atr is 2.56591606.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Average True Range (ATR) ChartMeditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Meditera Tibbi Malzeme Sanayi ve Ticaret AS. The current obv is 40,711,994.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Daily On-Balance Volume (OBV) ChartMeditera Tibbi Malzeme Sanayi ve Ticaret AS Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Meditera Tibbi Malzeme Sanayi ve Ticaret AS. The current mfi is 74.10.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Money Flow Index (MFI) ChartMeditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Meditera Tibbi Malzeme Sanayi ve Ticaret AS.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-05-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-05-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-05-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-05-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-06-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-29BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-27MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Meditera Tibbi Malzeme Sanayi ve Ticaret AS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.649
Ma 20Greater thanMa 5042.285
Ma 50Greater thanMa 10038.691
Ma 100Greater thanMa 20035.218
OpenGreater thanClose41.520
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Meditera with someone you think should read this too:
  • Are you bullish or bearish on Meditera? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Meditera? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Meditera Tibbi Malzeme Sanayi ve Ticaret AS

I send you an email if I find something interesting about Meditera Tibbi Malzeme Sanayi ve Ticaret AS.


Comments

How you think about this?

Leave a comment

Stay informed about Meditera Tibbi Malzeme Sanayi ve Ticaret AS.

Receive notifications about Meditera Tibbi Malzeme Sanayi ve Ticaret AS in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.